CD8A and myeloid sarcoma: For peripheral blood cells, we found upregulation of ARHGAP27 (Rho GTPase-activating protein 27) in CD4+ and CD8+ lymphocytes in MS patients compared to negative controls (idiopathic intracranial hypertension patients).